Although the use of TIPS significantly lowers portal pressure, it also increases the frequency of severe adverse events such as untreatable encephalopathy, and it can precipitate hepatic insufficiency 20.
El uso de TIPS, a pesar de bajar significativamente la presión portal, aumenta los eventos adversos severos como encefalopatía intratable o puede precipitar una insuficiencia hepática 20.